Portal:CPTAC/Intro
From WikiPathways
(updated url) |
Current revision (23:25, 3 December 2018) (view source) (added link to hallmark paper) |
||
| Line 4: | Line 4: | ||
'''This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).''' | '''This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).''' | ||
<p>The [https://www.cancer.gov/ National Cancer Institute], part of the National Institutes of Health, announced the launch of a [https://proteomics.cancer.gov/programs/cptac Clinical Proteomic Tumor Analysis Consortium] in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.</p> | <p>The [https://www.cancer.gov/ National Cancer Institute], part of the National Institutes of Health, announced the launch of a [https://proteomics.cancer.gov/programs/cptac Clinical Proteomic Tumor Analysis Consortium] in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.</p> | ||
| + | <p>The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see [https://www.ncbi.nlm.nih.gov/pubmed/21376230 Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011].</p> | ||
|align="right"|[[image:CPTAC-logo.png|200px]] | |align="right"|[[image:CPTAC-logo.png|200px]] | ||
|} | |} | ||
Current revision
Welcome to the CPTAC Pathway PortalThis portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC). The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public. The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011. | 
|
